Scholar Rock Holding Corp (FRA:2QK)
€ 25.2 0 (0%) Market Cap: 2.30 Bil Enterprise Value: 2.19 Bil PE Ratio: 0 PB Ratio: 16.57 GF Score: 50/100

Scholar Rock Holding Corp at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 11, 2021 / 10:20PM GMT
Release Date Price: €38
Anupam Rama
JPMorgan Chase & Co, Research Division - VP and Analyst

Welcome, everyone, to the 39th Annual JPMorgan Healthcare Conference. My name is Anupam Rama. I'm one of the senior biotech analysts here at JPMorgan. I'm joined by Tessa Romero and Matt Bannon from the team.

Our next presenting company is Scholar Rock. And presenting on behalf of the company, we have CEO, Tony Kingsley. Before I turn it over to Tony, just wanted to highlight to those on the webcast, you can submit a question to me. We have the ask-the-question feature in the portal. So I recommend you guys do that, and I'm happy to ask the question on your behalf.

With that, I'll pass it over to you, Tony. Tony?

Stuart Anthony Kingsley
Scholar Rock Holding Corporation - President, CEO & Director

Good. Thank you, Anupam, and good afternoon, everyone. Delighted to share the Scholar Rock story with you today. I'll start by pointing you to our disclaimers about forward-looking statements and the like on Page 2 of the presentation and encourage you to consult the risk

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot